Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.
Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Lancet Neurol. 2016 Mar;15(3):279-91. doi: 10.1016/S1474-4422(15)00151-9. Epub 2015 Oct 20.
Recent discoveries about the pathogenesis and symptom structure of autism spectrum disorders (ASDs) are challenging traditional nosology and driving efforts to reconceptualise the diagnosis of autism, a goal made all the more pressing by new prospects for early identification, targeted intervention, and personalised-medicine approaches to specific autistic syndromes. Recognition that ASD represents the severe end of a continuous distribution of social communication abilities in the general population has stimulated attempts to standardise the measurement of autistic traits and to set appropriate clinical thresholds for diagnosis. Over the next decade, rapid advances in our understanding of symptom structure and the diversity of causes of ASD could be incorporated into the next evolution in the diagnosis of autism, with important implications for research, clinical practice, public health, and policy. As differential effects of personalised therapies are identified in relation to specific causes of autism, the benefits of an updated diagnostic nosology will translate into the delivery of more effective care for patients.
自闭症谱系障碍(ASD)的发病机制和症状结构的最新发现正在挑战传统的分类学,并推动人们重新构想自闭症的诊断,新的早期识别、有针对性干预和针对特定自闭症综合征的个体化医学方法的前景使这一目标更加紧迫。认识到 ASD 代表了一般人群中社会沟通能力连续分布的严重端,这激发了人们尝试标准化自闭症特征的测量,并为诊断设定适当的临床阈值。在未来十年,我们对症状结构和 ASD 病因多样性的理解的快速进展,可以纳入自闭症诊断的下一个演变,这对研究、临床实践、公共卫生和政策都有重要意义。随着与自闭症特定病因相关的个体化治疗的差异效果的确定,更新的诊断分类学的益处将转化为为患者提供更有效的护理。